Literature DB >> 3491589

Reoperations for valve surgery: perioperative mortality and determinants of risk for 1,000 patients, 1958-1984.

B W Lytle, D M Cosgrove, P C Taylor, C C Gill, M Goormastic, L R Golding, R W Stewart, F D Loop.   

Abstract

One thousand consecutive cardiac reoperations for valve surgery in 897 patients were reviewed to determine in-hospital mortality and indicators of risk. Subgroups based on the number of previous cardiac procedures and the valve or valves replaced or repaired at reoperation (aortic valve, mitral valve, tricuspid valve, or multiple valves and mortality [deaths/number of procedures (% mortality)]) for those subgroups are as follows: (Table: see text) Predictors of increased risk for a first aortic valve reoperation were advanced age (p = .0002), endocarditis (p = .0018), female sex (p = .014), impaired left ventricular function (p = .039), and number of coronary vessels obstructed by 70% or more (p = .055). For a first mitral valve reoperation, the predictors were advanced age (p less than .0001), preoperative shock or cardiac arrest (p = .01), previous aortic or tricuspid valve operations (p = .02), type of mitral valve procedure (risk for repair of periprosthetic leak was greater than mitral valve replacement which was greater than mitral valve-conserving operation [p = .05]), and impaired left ventricular function (p = .059). For a first multiple valve reoperation, the predictors were diabetes (p = .04) and ascites (p = .02), whereas patients undergoing mitral valve replacement and tricuspid valve operations were at decreased risk (p = .01). Comparison of second reoperations with first reoperations indicates risk increases for multiple operations (p = .01) but not for aortic or mitral valve procedures. Rereplacement of a prosthesis (p = .007), coronary bypass grafting at reoperation (p = .006), and advanced age (p = .06) increased the risk for second reoperations. Age is the most consistent predictor of risk for patients undergoing valve reoperations.

Entities:  

Mesh:

Year:  1986        PMID: 3491589     DOI: 10.1016/s0003-4975(10)64597-3

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  14 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Second and third cardiac valve reoperations: factors influencing death and long-term survival.

Authors:  Mehmet Erdem Toker; Ercan Eren; Mustafa Guler; Kaan Kirali; Mehmet Yanartas; Mehmet Balkanay; Cevat Yakut
Journal:  Tex Heart Inst J       Date:  2009

3.  Risk factors for short- and long-term survival in patients undergoing re-replacement due to prosthetic valve dysfunction.

Authors:  Bilgehan Savaş Oz; Hikmet Iyem; Hakki Tankut Akay; Cengiz Bolcal; Mehmet Yokusoglu; Erkan Kuralay; Ufuk Demirkilic; Harun Tatar
Journal:  Heart Vessels       Date:  2006-11-27       Impact factor: 2.037

4.  Valvular heart disease. A comparative study of results after primary operation, reoperation, and after multiple reoperation.

Authors:  K Ataka; M Okada; C Yamashita; T Yamashita; H Wakiyama; K Nakagiri; N Yoshimura
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-08

Review 5.  Current state of transcatheter mitral valve implantation in bioprosthetic mitral valve and in mitral ring as a treatment approach for failed mitral prosthesis.

Authors:  Vratika Agarwal; Ryan K Kaple; Hetal H Mehta; Prabhjot Singh; Vinayak N Bapat
Journal:  Ann Cardiothorac Surg       Date:  2021-09

6.  Outcomes of reoperative aortic valve replacement after previous sternotomy.

Authors:  Damien J LaPar; Zequan Yang; George J Stukenborg; Benjamin B Peeler; John A Kern; Irving L Kron; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2009-12-16       Impact factor: 5.209

7.  Combined PCI and minimally invasive heart valve surgery for high-risk patients.

Authors:  Ramanan Umakanthan; Marzia Leacche; Michael R Petracek; David X Zhao; John G Byrne
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-12

8.  The risks of reoperation for prosthetic valve dysfunction.

Authors:  Y Kawachi; K Matuzaki; R Tominaga; H Yasui; K Tokunaga
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

9.  Reoperation for prosthetic heart valve dysfunction: 19 years' experience.

Authors:  Z Masri; R Girardet; A Attum; R Barbie; I Yared; A Lansing
Journal:  Tex Heart Inst J       Date:  1990

10.  Percutaneous closure of a left ventricular pseudoaneurysm in a high-risk surgical candidate.

Authors:  Biswajit Kar; Gunjan Gholkar; Igor D Gregoric; Surendra K Jain; Pranav Loyalka
Journal:  Tex Heart Inst J       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.